Showing results (1091-1100 of 1,286) with videos related to
Sort By:
Pageof 129
Scientific Reports|April 11, 2018
Plac1 Is a Key Regulator of the Inflammatory Response and Immune Tolerance In Mammary TumorigenesisHongyan Yuan, Xiaoyi Wang, Chunmei Shi, et al.Optics Express|November 10, 2016
Integrated line-by-line optical pulse shaper for high-fidelity and rapidly reconfigurable RF-filteringAndrew J Metcalf, Hyoung-Jun Kim, Daniel E Leaird, et al.Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|March 10, 2017
Cerebral venous sinus thrombosis in pregnancy and puerperium: A pooled, systematic reviewAhmed I Kashkoush, Henry Ma, Nitin Agarwal, et al.Blood|May 15, 1995
CD16+ monocytes in patients with cancer: spontaneous elevation and pharmacologic induction by recombinant human macrophage colony-stimulating factorM N Saleh, S J Goldman, A F LoBuglio, et al.Protein Engineering|March 1, 1995
Engineering disulfide-linked single-chain Fv dimers [(sFv')2] with improved solution and targeting properties: anti-digoxin 26-10 (sFv')2 and anti-c-erbB-2 741F8 (sFv')2 made by protein folding and bonded through C-terminal cysteinyl peptidesJ E McCartney, M S Tai, R M Hudziak, et al.Nature|September 6, 1990
Human dopamine D1 receptor encoded by an intronless gene on chromosome 5R K Sunahara, H B Niznik, D M Weiner, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 1, 1995
Enhanced tumor specificity of 741F8-1 (sFv')2, an anti-c-erbB-2 single-chain Fv dimer, mediated by stable radioiodine conjugationG P Adams, J E McCartney, E J Wolf, et al.Journal of Psychiatric Research|April 3, 2012
Striatal activity in borderline personality disorder with comorbid intermittent explosive disorder: sex differencesM Mercedes Perez-Rodriguez, Erin A Hazlett, Erin L Rich, et al.Cancer Immunology, Immunotherapy : CII|May 1, 1995
Optimization of in vivo tumor targeting in SCID mice with divalent forms of 741F8 anti-c-erbB-2 single-chain Fv: effects of dose escalation and repeated i.v. administrationG P Adams, J E McCartney, E J Wolf, et al.Cancer Chemotherapy and Pharmacology|October 3, 2002
Phase I and pharmacokinetic study of irinotecan in combination with raltitrexedNancy L Lewis, Richard Scher, James M Gallo, et al.Pageof 129